1. Home
  2. VC vs DYN Comparison

VC vs DYN Comparison

Compare VC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$112.40

Market Cap

2.6B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.60

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
DYN
Founded
2000
1984
Country
United States
United States
Employees
10000
258
Industry
Auto Parts:O.E.M.
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
VC
DYN
Price
$112.40
$17.60
Analyst Decision
Buy
Strong Buy
Analyst Count
13
14
Target Price
$125.50
$37.00
AVG Volume (30 Days)
654.4K
1.6M
Earning Date
04-23-2026
05-04-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$3,768,000,000.00
N/A
Revenue This Year
$2.39
N/A
Revenue Next Year
$5.21
N/A
P/E Ratio
$100.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.21
$8.25
52 Week High
$128.32
$25.00

Technical Indicators

Market Signals
Indicator
VC
DYN
Relative Strength Index (RSI) 65.51 45.24
Support Level $106.64 $16.47
Resistance Level $117.66 $19.65
Average True Range (ATR) 4.47 0.97
MACD 0.41 -0.15
Stochastic Oscillator 74.14 18.41

Price Performance

Historical Comparison
VC
DYN

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: